Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
10.71
+0.25 (2.39%)
Mar 4, 2026, 4:00 PM EST - Market closed
Medifast Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Medifast stock has a target of 12, which predicts an increase of 12.04% from the current stock price of 10.71.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Medifast is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +12.04% | Feb 19, 2026 |
| DA Davidson | DA Davidson | Hold Maintains $17 → $17 | Hold | Maintains | $17 → $17 | +54.06% | Feb 19, 2025 |
| DA Davidson | DA Davidson | Sell → Hold Upgrades $17 → $17 | Sell → Hold | Upgrades | $17 → $17 | +58.73% | Nov 5, 2024 |
| DA Davidson | DA Davidson | Sell Maintains $18 | Sell | Maintains | $18 | +63.40% | Jul 22, 2024 |
| DA Davidson | DA Davidson | Hold → Sell Downgrades $25 → $18 | Hold → Sell | Downgrades | $25 → $18 | +63.40% | Jun 5, 2024 |
Financial Forecast
Revenue This Year
355.62M
from 385.79M
Decreased by -7.82%
Revenue Next Year
n/a
from 355.62M
EPS This Year
-0.13
from -1.70
EPS Next Year
n/a
from -0.13
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 369.7M |
| Avg | 355.6M |
| Low | 345.1M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | -4.2% |
| Avg | -7.8% |
| Low | -10.6% |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | 1.42 |
| Avg | -0.13 |
| Low | -1.58 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.